# Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders

> **NCT05134584** · PHASE4 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 78 (estimated)

## Conditions studied

- Functional Dyspepsia
- Constipation-predominant Irritable Bowel Syndrome

## Interventions

- **DRUG:** Linaclotide
- **DRUG:** Lactulose
- **DRUG:** Omeprazol
- **DRUG:** Itopride

## Key facts

- **NCT ID:** NCT05134584
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-02
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2021-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05134584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05134584, "Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05134584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*